about
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of no...
Read More
11.83
0.70
(6.29%)
41,055
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
FibroGen Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..